
    
      Subjects enrolled in the study will be placed in one of twelve treatment arms. Subjects in
      each of the twelve treatment regimens will receive either varenicline or bupropion or
      long-acting nicotine replacement therapy, with or without use of supplemental nicotine
      replacement therapy, and in combination with either standard of care smoking cessation
      counseling or high intensity/motivational smoking cessation counseling.
    
  